Tag: TC6987

Posted on

Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987 – NASDAQ

Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987
NASDAQ
(RTTNews.com) – Targacept Inc. (TRGT) announced revised top-line results from its exploratory Phase 2 clinical study of TC-6987 in asthma. After identifying an error in the application of the agreed statistical analysis plan, a reanalysis of the data …
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of …MarketWatch (press release)
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 StudyBenzinga

all 9 news articles »

View full post on asthma – Google News

Posted on

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987 – RTT News

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987
RTT News
(RTTNews) – Targacept Inc. (TRGT: News ) announced top-line results from two separate exploratory Phase 2 studies of its product candidate TC-6987 conducted in the US, one in asthma and one in type 2 diabetes. In the asthma study, oral TC-6987 met …
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of …MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

Posted on

Targacept Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … – EON: Enhanced Online News (press release)

Targacept Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and …
EON: Enhanced Online News (press release)
TC-6987 demonstrated a potent anti-inflammatory response in a variety of preclinical studies conducted by Targacept, including models of asthma and diabetes …
Targacept to begin phase 2 trials for its anti-inflammatory drug compoundWinston-Salem Journal
Targacept starts new trial for diabetes drugBizjournals.com

all 13 news articles »

View full post on asthma – Google News